Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Ephrin A1 ELISA Kit (AC2944)
Cat.#: ASET-1533
Specifications
Description Human Ephrin A1 ELISA Kit allows for the in vitro quantitative determination of human Ephrin A1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1353 Human Eph Receptor A3 ELISA Kit (AC2764) Quantitative inquiry ASET-2352 Hamster Leptin ELISA Kit (AC3763) Quantitative inquiry ASET-2392 Mouse Huntingtin ELISA Kit (AC3803) Quantitative inquiry ASET-2513 Human AMPK alpha 1 ELISA Kit (AC3924) Quantitative inquiry ASET-1173 Mouse Wnt8b ELISA Kit (AC2584) Quantitative inquiry ASET-1375 Human KIAA1199 ELISA Kit (AC2786) Quantitative inquiry ASET-1917 Human Leptin ELISA Kit (AC3328) Quantitative inquiry ASET-1798 Human TMEM126A ELISA Kit (AC3209) Quantitative inquiry ASET-2034 Rat Contactin 1 ELISA Kit (AC3445) Quantitative inquiry ASET-2425 Human DYRK1A ELISA Kit (AC3836) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket